'Reverse discordance' between 68Ga-DOTA-NOC PET/CT and 177Lu-DOTA-TATE posttherapy scan: the plausible explanations and its implications for high-dose therapy with radiolabeled somatostatin receptor analogs

Riferimento: 
Nucl Med Commun. 2011 Jul;32(7):654-8.
Autori: 
Basu S, Abhyankar A, Kand P, Kumar R, Asopa R, Rajan MG, Nayak U, Shimpi H, Das T, Venkatesh M, Chakrabarty S,Banerjee S.
Fonte: 
Nucl Med Commun. 2011 Jul;32(7):654-8.
Anno: 
2011
Azione: 
Possibili implicazioni per le decisioni terapeutiche con i recettori degli analoghi radioattivi della somatostatina.
Target: 
Recettori somatostatina/possibili implicazioni terapeutiche.

ABSTRACT
In this technical note, an unusual discordance between diagnostic and posttherapeutic scan resulting from the use of different somatostatin receptor ligands in two settings is described. Such observation, we believe, is multifactorial, but most importantly arises due to different receptor affinity profile of the ligands and different somatostatin receptor subtype expression in different tumors. It is important for the treating physician to be aware of this phenomenon that would aid in improving our understanding of complex ligand-receptor interactions in various somatostatin receptor-positive tumors with its possible implications for therapeutic decision making with radiolabeled somatostatin receptor analogues.